CHANNING KAY: Open Payments
NPI 1346905650 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 21 payments from 3 companies in 2025. Trend: 2023 $237 · 2024 $184 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $278 |
| Janssen Pharmaceuticals, Inc | 4 | $176 |
| E.R. Squibb & Sons, L.L.C. | 1 | $92 |
Products named: INGREZZA, INVEGA SUSTENNA, COBENFY.
Industry payments across AZ — which companies pay providers there.
